• Facebook Live Webinar
• Thursday, November 26, 2020
• Program 14:30, Close 15:30 (HK Time / GMT +8)

On January 30, the World Health Organization declared a global health emergency on the spread of the novel coronavirus (Covid-19) that originated in Wuhan, China. Healthcare experts have warned that Covid-19 could rapidly spread, if not properly contained, and many governments around the world have begun to take precautionary measures to ensure public health safety. Amid the international concern and heightened fears about the disease, what is fact and what is fiction? The Asia Society Hong Kong Center brings you regular updates on the coronavirus story in Hong Kong that has reverberations elsewhere in the world. We are pleased to present on-the-ground public health experts and internationally renowned specialists with the latest facts and evidence-based findings regarding this epidemic outbreak. In episode 24, hear from Prof. Honglin Chen from State Laboratory of Infectious Diseases, HKU and Dr. Kiat Ruxrungtham, Professor of Medicine, Department of Medicine Chulalongkorn University.

Prof. Honglin Chen graduated from Xiamen University in 1983 with BSc in Biology and completed his PhD study at the University of Hong Kong in 1992, working on pathogenesis of Epstein-Barr virus (EBV) in nasopharyngeal carcinoma (NPC).  He went on to continue his post-doctoral research on tumor virus at John Hopkins University School of Medicine in 1997. Prof. Chen re-joined the University of Hong Kong in 2003 and has since expanded his research scopes to RNA viruses including emerging influenza and coronaviruses.  He has since established several research programs which focus on studying molecular determinants for cross species of avian influenza viruses and coronavirus. His research on the NS1 protein of influenza virus has led to the establishment of a unique DelNS1 live attenuated influenza vaccine platform which can be used to develop vaccines for other viruses. 

Dr Kiat Ruxrungtham is a Professor of Medicine, Department of Medicine Chulalongkorn University; and Scientific Chair of the Chula Vaccine Research Center (ChulaVRC). He is also the Ex-Vice President for Research, Chulalongkorn University; and the Ex-Vice Dean for Research, Faculty of Medicine, Chulalongkorn University

He is providing teaching and patient care at the King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University; and is mentoring junior researchers on HIV, vaccine, immunology research and also on clinical trials. He has published more than 300 peer review papers on HIV, immunology, vaccine and allergy. 

He is a faculty member of the faculty 1000 of Medicine, an editorial board member of the Scientific Report, Global Health & Medicine, Asian Pacific J of Allergy and Immunology (Chief Editor), and ImmunoTargets and Therapy.

Got Questions? Ask Them Here!

Register Here: https://ticketing.asiasociety.org.hk/Index?eventId=a0l2v000009PJT7